- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
ViroPharma Inc+ Add to Watchlist
VPHM:US26.1000 USD 0.2400 0.93%
As of 16:00:00 ET on 05/22/2013.
Company Profile for ViroPharma Inc (VPHM)
ViroPharma Incorporated is a biopharmaceutical company committed to the commercialization, development, and discovery of new medicines. The Company's products include a treatment for prophylaxis of hereditary angioedema as well a capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis.
Key Executives for ViroPharma Inc (VPHM)
|Vincent J Milano "Vin"Chairman/President/CEO||Charles A Rowland JrVP/CFO|
|Daniel B SolandVP/COO||Colin BroomVP/Chief Scientific Officer|
|Robert G PietruskoVP:Regulatory||J Peter WolfVP/Secretary/Gen Cnsl|